Abstract:In silico immunogenicity risk assessment has been an important step in the development path for many biologic therapeutics, including monoclonal antibodies. Even if the source of a given biologic is 'fully human', T cell epitopes that are contained in the sequences of the biologic may activate the immune system, enabling the development of anti-drug antibodies that can reduce drug efficacy and may contribute to adverse events. Computational tools that identify T cell epitopes from primary amino acid sequences have been used to assess the immunogenic potential of therapeutic candidates for several decades. To facilitate larger scale analyses and accelerate preclinical immunogenicity risk assessment, our group developed an integrated web-based platform called ISPRI, (Immunogenicity Screening and Protein Re-engineering Interface) that provides hands-on access through a secure web-based interface for scientists working in large and mid-sized biotech companies in the US, Europe, and Japan. This toolkit has evolved and now contains an array of algorithms that can be used individually and/or consecutively for immunogenicity assessment and protein engineering. Most analyses start with the advanced epitope mapping tool (EpiMatrix), then proceed to identify epitope clusters using ClustiMer, and then use a tool called JanusMatrix to define whether any of the T cell epitope clusters may generate a regulatory T cell response which may diminish or eliminate anti-drug antibody formation. Candidates can be compared to similar products on a normalized immunogenicity scale. Should modifications to the biologic sequence be an option, a tool for moderating putative immunogenicity by editing T cell epitopes out of the sequence is available (OptiMatrix). Although this perspective discusses the in-silico immunogenicity risk assessment for monoclonal antibodies, bi-specifics, multi-specifics, and antibody-drug conjugates, the analysis of additional therapeutic modalities such as enzyme replacement proteins, blood factor proteins, CAR-T, gene therapy products, and peptide drugs is also made available on the ISPRI platform. ISPRI (Interactive Screening and Protein Reengineering Interface) : Integrated, cloud-based, comprehensive toolkit for Immunogenicity Risk Assessment. EpiMatrix Immunogenicity Score : Combined T effector and Treg Epitope Content per unit protein. Tregitopes : Treg Epitopes found in IgG Framework that have been shown to modulate antigen-specific effector T cell responses. ClustiMer : Tool for identifying epitope rich polypeptides from within a given protein sequence. JanusMatrix : Tool for Predicting Tolerance, Putative Treg Epitopes, and Anti-self-immune responses. OptiMatrix : Tool for modifying T cell epitope sequences to reduce (or enhance) MHC binding.

SOS: Online probability estimation and generation of T and B cell receptors

OLGA: fast computation of generation probabilities of B- and T-cell receptor amino acid sequences and motifs

IGoR: a tool for high-throughput immune repertoire analysis

repgenHMM: a dynamic programming tool to infer the rules of immune receptor generation from sequence data

Population variability in the generation and thymic selection of T-cell repertoires

SCIGA: Software for large-scale, single-cell immunoglobulin repertoire analysis

Deep generative selection models of T and B cell receptor repertoires with soNNia

T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing

TCRosetta: a powerful server for analyzing and annotating T-cell receptor repertoire

Current Status and Recent Advances of Next Generation Sequencing Techniques in Immunological Repertoire

Echidna: integrated simulations of single-cell immune receptor repertoires and transcriptomes

T-Cell Receptor Repertoire Analysis with Computational Tools-An Immunologist's Perspective

Basic Research And Clinical Application Of Immune Repertoire Sequencing

Scaling Monte-Carlo-Based Inference on Antibody and TCR Repertoires

Statistical inference of the generation probability of T-cell receptors from sequence repertoires

Ab-origin: an enhanced tool to identify the sourcing gene segments in germline for rearranged antibodies

IGHV allele similarity clustering improves genotype inference from adaptive immune receptor repertoire sequencing data

Combining mutation and recombination statistics to infer clonal families in antibody repertoires

In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies

Highly Sensitive And Unbiased Approach For Elucidating Antibody Repertoires

Exploring and analysing immune single cell multi-omics data with VDJView